Anal Dysplasia Clinic MidWest is involved in various clinical trials. For more information and/or to participate in one of our studies, click on one of the links below or give us a call at 312-623-2625.
This study compares topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immunodeficiency virus (HIV) and high-grade squamous intraepithelial lesions (HSIL).
This study evaluates the use of ABI-1968, a topical cream, in the treatment of anal precancerous lesions in adults with and without human immunodeficiency virus (HIV) infection
This is an open-label efficacy study of VGX-3100 administered by intramuscular (IM) injection followed by electroporation (EP) in adults who are human immunodeficiency virus (HIV) negative with histologically confirmed anal or anal/peri-anal high-grade squamous intraepithelial lesion (HSIL).